Patient Sustains Permanent Brain Damage After Tumor Resection

ByVictoria Negron

|

Updated on

Patient Sustains Permanent Brain Damage After Tumor Resection

This case involves an otherwise healthy 40-year-old female who had a large noncancerous tumor removed from the membrane surrounding her brain. Pathology revealed higher than the normal cell proliferation, but the pathologist did not diagnose the lesion as an atypical or malignant tumor. After the brain surgery, the patient felt persistent weakness in her legs. Subsequent spinal imaging revealed a spine tumor which was subsequently resected. The surgeon did not order follow up imaging or refer the patient for radiosurgery. 5 years later, the patient’s condition began to rapidly deteriorate. It was discovered that the lesion had recurred and increased in size. The patient underwent a second craniotomy for resection and suffered complications as a result. The patient suffered permanent brain damage and lost much of her mental function. It was alleged that initial post-operative imaging may have revealed a residual tumor. An expert neurosurgeon with experience treating patients with atypical tumors was sought to review the records and opine on the standard of care.

Question(s) For Expert Witness

1. What is the standard imaging surveillance for a patient with an atypical meningioma and/or multiple meningiomas within a short period?

2. What is the role of radiosurgery in the treatment of residual atypical meningiomas?

Expert Witness Response E-007891

inline imageI am a board-certified neurosurgeon with 30+ years of experience. I am currently the chief of service, chair of the neurosurgery department, and program director at my institution. I think it is fair to say that many neurosurgeons maintain close (at least annual) surveillance of residual meningiomas. The literature related to recurrence rates for these tumors given extent of resection is widely available. Radiosurgery has a role, although there is controversy surrounding re-operation vs radiosurgery. Generally, residual atypical meningioma is not ignored. Non-malignant residual meningiomas are also usually followed carefully. After reading this case summary, I have some questions: Do we have any idea why follow up did not occur in this case? Was the patient seen regularly? Were scans scheduled but skipped by patient? My first instinct is that the case seems strange, although examples of lapsed follow up and surveillance can occur from time to time.

About the author

Victoria Negron

Victoria Negron

Victoria Negron has extensive experience in journalism and thought leadership in the legal space, with a background crafting content, whitepapers, webinars, and current event articles pertaining to the role of expert witnesses in complex litigation matters. She is a skilled professional specializing in B2B product marketing and content marketing. Currently, she serves as an Enterprise Product Marketing Manager at Postman, and previously held the position of Technical Product Marketing Manager at Palantir Technologies, where she developed her skills in launch strategies, go-to-market strategy, and competitive analysis.

Her expertise in content marketing was further refined during her tenure at the Expert Institute, where she progressed from a Marketing Writer to Senior Content Marketing Manager, and eventually to Associate Director of Content & Product Marketing. In these roles, she honed her abilities in digital marketing, SEO, content strategy, and thought leadership.

Educationally, Victoria holds a Master of Business Administration from the University of Florida - Warrington College of Business and a Bachelor of Arts in Literature, Art, and Hispanic Studies from Hamilton College. Her diverse educational background and professional experience have equipped her with a robust skill set in product marketing, content development, and strategic marketing initiatives.

Find an expert witness near you

What State is your case in?

What party are you representing?

background image

Subscribe to our newsletter

Join our newsletter to stay up to date on legal news, insights and product updates from Expert Institute.